BFLY · NYSE · Medical - Devices

Butterfly Network

Builds chip-based handheld ultrasound devices with connected workflow software.

$8.47
After-hours close+0.04 (+0.45%)
At close$8.43(−3.33%)
Loading prices…

Profile

Butterfly Network, Inc.BFLYHealth Care

Sells single-probe ultrasound devices, accessories, subscriptions, and workflow services to healthcare providers. The platform pairs iQ hardware with Compass AI software and an Ultrasound-on-Chip licensing program, with sales concentrated in the United States but extending across international markets.

Builds a point-of-care ultrasound platform around iQ handheld probes, accessories, software subscriptions, and workflow services. The third-generation iQ probe is the current flagship device, while iQ+ and iQ+ Bladder remain part of the marketed portfolio.

Compass AI adds enterprise workflow software for scan intake, documentation, EMR and PACS connectivity, proficiency management, and education content. Butterfly Embedded licenses Ultrasound-on-Chip technology for non-competitive healthcare markets and adjacent ultrasound-enabled uses.

Sales are concentrated in the United States while products reach international markets through direct sales, distributors, and eCommerce. The business depends on medical-device clearances, hospital workflow adoption, software attachment, and acceptance of semiconductor-based ultrasound versus cart-based incumbents.

Company facts

CEOJoseph M. DeVivo
ListedFeb 16, 2021
ExchangeNYSE
HeadquartersBurlington, MA
CountryUnited States
Employees220
CIK0001804176
ISINUS1241551027

Key statistics

Market cap$2.24B
EPS (ttm)−$0.2894
P/E (ttm)−29.13
ROE-38.4%
P/B11.67
P/S20.02
Dividend yield
Beta3.36vs XLV 0.22

Year to date +125% · Average volume (30d) 6.2M

Analysts

Price target, next 12 months$5.50−34.8%Median of 7 analysts · vs the Aug 28 close
ConsensusBuy6 of 7 analysts rate it buy or better

Ratings

Target range

Latest analyst notes

DateFirmActionRatingPrior targetTarget
Mar 2, 2026Loop Capital MarketsTarget$5$5.50
Jan 21, 2026Craig-HallumTarget$2$5.25
Jan 20, 2026Lake StreetReiterateBuy$5$5.50
Dec 31, 2025Loop Capital MarketsTarget$5

Earnings

EPS

Estimate−$0.03
ReportedDue Oct 30, 2026

Revenue

Estimate$28.2M
ReportedDue Oct 30, 2026

History

Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseNext session
Jul 30, 2026Q2 FY26−$0.04−$0.01+71.4%$29.2M$32.6M+11.8%+15.07%
Apr 30, 2026Q1 FY26−$0.04−$0.03+25.0%$26.1M$26.5M+1.7%+12.73%
Feb 26, 2026Q4 FY25−$0.04−$0.02+50.0%$25.9M$31.5M+21.6%−18.84%
Oct 31, 2025Q3 FY25−$0.07−$0.13−85.7%$26.3M$21.5M−18.1%+8.18%
View details

Financial highlights

12 quartersQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$21.2M$23.4M$21.5M$31.5M$26.5M$32.6M
Gross profit$13.4M$14.9M−$3.8M$21.2M$18.3M$23.3M
Operating income−$18.5M−$16.1M−$32.4M−$19.5M−$13.9M−$13.7M
Net income−$14.0M−$13.8M−$34.0M−$15.3M−$12.7M−$12.9M
Diluted EPS−$0.06−$0.06−$0.13−$0.06−$0.05−$0.05
Gross margin63.0%63.7%-17.5%67.3%68.9%71.4%
Operating margin-87.0%-68.9%-150.7%-61.8%-52.3%-41.9%

Fiscal years (4-quarter sums)FY21 $62.6M · FY22 $73.4M · FY23 $65.9M · FY24 $82.1M · FY25 $97.6M

Revenue by product · Q2 FY26

Software And Other Services$16.9M · 52%
Product$15.7M · 48%

Revenue by geography · Q2 FY26

United States$27.6M · 85%
Non-US$5.0M · 15%

Balance sheet, Jun 30, 2026Cash & short-term investments $124.7M · Total debt $19.1M · Total assets $283.0M · Shareholders' equity $189.4M

Dividends

No dividends on record.

Ownership

Institutions 60.79%161.88M sharesInsiders 8.24%21.95M sharesOther 30.97%82.46M shares

Shares outstanding 266.29M · Float 203.13M · 76.3% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
FMR LLC28.95M11.80%13GAug 7, 2026
BlackRock, Inc.18.82M7.07%13FAug 7, 2026
Glenview Capital Management, LLC14.34M5.38%13FAug 14, 2026
Hood River Capital Management LLC13.19M5.61%13GAug 14, 2026
Fosun International Ltd10.23M3.84%13FAug 12, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 17, 2026Larry Robbinsdirector−582,500$8.97
Aug 14, 2026Larry Robbinsdirector−824,700$8.70
Aug 13, 2026Larry Robbinsdirector−890,533$9.24
Aug 14, 2026S. Louise Phanstieldirector+115,200$8.68
Aug 11, 2026Nicholas Caezzaofficer: Deputy General Counsel−10,000$9.75
View details

Peers

  • GE HealthCare

    Broad POCUS hardware, AI guidance, and workflow incumbent

  • Philips (ADR)

    Handheld Lumify and hospital ultrasound portfolio overlap POCUS adoption

CompareAfter-hours close

CompanyPriceChange
Butterfly Network$8.47+0.45%$2.24B20.0+39.5%
GE HealthCare$71.73−0.01%$32.40B20.813.81.6+5.8%
Philips (ADR)$26.72+0.06%$26.12B19.913.71.3−2.9%
Median20.313.71.4+1.4%